+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pharmacovigilance and Drug Safety Software Market 2024-2028

  • PDF Icon

    Report

  • 145 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5309579
1h Free Analyst Time

The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals of new molecules and biosimilars

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmacovigilance and drug safety software market is forecasted to grow by USD 69.1 million during 2023-2028, accelerating at a CAGR of 6.81% during the forecast period. The report on the pharmacovigilance and drug safety software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals of new molecules and biosimilars.

The pharmacovigilance and drug safety software market is segmented as below:

By End-user

  • Pharmaceutical and biotechnology companies
  • Contract research organization
  • Business process outsourcing

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the integration of ai in pharmacovigilance as one of the prime reasons driving the pharmacovigilance and drug safety software market growth during the next few years. Also, outsourcing pharmacovigilance and drug safety research to contract research organization (cros) and extensive adoption of cloud technologies in pharmaceutical manufacturing and testing will lead to sizable demand in the market.

The report on the pharmacovigilance and drug safety software market covers the following areas:

  • Pharmacovigilance and drug safety software market sizing
  • Pharmacovigilance and drug safety software market forecast
  • Pharmacovigilance and drug safety software market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacovigilance and drug safety software market vendors that include AB Cube SARL, Accenture Plc, Advera Health Analytics Inc., ArisGlobal LLC, BaseCon AS, Clarivate PLC, Cognizant Technology Solutions Corp., Ennov SAS, EXTEDO GmbH, Honeywell International Inc., Indegene Pvt. Ltd., IQVIA Holdings Inc., Max Application Srl, Oracle Corp., Pegasystems Inc., Sarjen Systems Pvt. Ltd., United BioSource LLC, Veeva Systems Inc., and Wipro Ltd. Also, the pharmacovigilance and drug safety software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Pharmacovigilance And Drug Safety Software Market 2018 - 2022
  • Historic Market Size - Data Table on Global Pharmacovigilance And Drug Safety Software Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
  • Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
  • Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
6.4 Contract research organization - Market size and forecast 2023-2028
  • Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
  • Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
  • Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
  • Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
6.5 Business process outsourcing - Market size and forecast 2023-2028
  • Chart on Business process outsourcing - Market size and forecast 2023-2028 ($ million)
  • Data Table on Business process outsourcing - Market size and forecast 2023-2028 ($ million)
  • Chart on Business process outsourcing - Year-over-year growth 2023-2028 (%)
  • Data Table on Business process outsourcing - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)
7 Customer Landscape
7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 France - Market size and forecast 2023-2028
  • Chart on France - Market size and forecast 2023-2028 ($ million)
  • Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Chart on France - Year-over-year growth 2023-2028 (%)
  • Data Table on France - Year-over-year growth 2023-2028 (%)
8.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.10 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
  • Overview on factors of disruption
10.4 Industry risks
  • Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
  • Companies covered
11.2 Market positioning of companies
  • Matrix on companies position and classification
11.3 AB Cube SARL
  • AB Cube SARL - Overview
  • AB Cube SARL - Product / Service
  • AB Cube SARL - Key offerings
11.4 ArisGlobal LLC
  • ArisGlobal LLC - Overview
  • ArisGlobal LLC - Product / Service
  • ArisGlobal LLC - Key offerings
11.5 BaseCon AS
  • BaseCon AS - Overview
  • BaseCon AS - Product / Service
  • BaseCon AS - Key offerings
11.6 Ennov SAS
  • Ennov SAS - Overview
  • Ennov SAS - Product / Service
  • Ennov SAS - Key offerings
11.7 EXTEDO GmbH
  • EXTEDO GmbH - Overview
  • EXTEDO GmbH - Product / Service
  • EXTEDO GmbH - Key news
  • EXTEDO GmbH - Key offerings
11.8 Honeywell International Inc.
  • Honeywell International Inc. - Overview
  • Honeywell International Inc. - Business segments
  • Honeywell International Inc. - Key news
  • Honeywell International Inc. - Key offerings
  • Honeywell International Inc. - Segment focus
11.9 Indegene Pvt. Ltd.
  • Indegene Pvt. Ltd. - Overview
  • Indegene Pvt. Ltd. - Product / Service
  • Indegene Pvt. Ltd. - Key offerings
11.10 Oracle Corp.
  • Oracle Corp. - Overview
  • Oracle Corp. - Business segments
  • Oracle Corp. - Key news
  • Oracle Corp. - Key offerings
  • Oracle Corp. - Segment focus
11.11 Sarjen Systems Pvt. Ltd.
  • Sarjen Systems Pvt. Ltd. - Overview
  • Sarjen Systems Pvt. Ltd. - Product / Service
  • Sarjen Systems Pvt. Ltd. - Key offerings
11.12 United BioSource LLC
  • United BioSource LLC - Overview
  • United BioSource LLC - Product / Service
  • United BioSource LLC - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
12.4 Research methodology
  • Research methodology
12.5 Data procurement
  • Information sources
12.6 Data validation
  • Data validation
12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
12.8 Data synthesis
  • Data synthesis
12.9 360 degree market analysis
  • 360 degree market analysis
12.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Pharmacovigilance And Drug Safety Software Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Business process outsourcing - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Business process outsourcing - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Business process outsourcing - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Business process outsourcing - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 51: Chart on Geographic comparison
Exhibits 52: Data Table on Geographic comparison
Exhibits 53: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 89: Market opportunity By Geographical Landscape ($ million)
Exhibits 90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2023 and 2028
Exhibits 92: Overview on criticality of inputs and factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Companies covered
Exhibits 96: Matrix on companies position and classification
Exhibits 97: AB Cube SARL - Overview
Exhibits 98: AB Cube SARL - Product / Service
Exhibits 99: AB Cube SARL - Key offerings
Exhibits 100: ArisGlobal LLC - Overview
Exhibits 101: ArisGlobal LLC - Product / Service
Exhibits 102: ArisGlobal LLC - Key offerings
Exhibits 103: BaseCon AS - Overview
Exhibits 104: BaseCon AS - Product / Service
Exhibits 105: BaseCon AS - Key offerings
Exhibits 106: Ennov SAS - Overview
Exhibits 107: Ennov SAS - Product / Service
Exhibits 108: Ennov SAS - Key offerings
Exhibits 109: EXTEDO GmbH - Overview
Exhibits 110: EXTEDO GmbH - Product / Service
Exhibits 111: EXTEDO GmbH - Key news
Exhibits 112: EXTEDO GmbH - Key offerings
Exhibits 113: Honeywell International Inc. - Overview
Exhibits 114: Honeywell International Inc. - Business segments
Exhibits 115: Honeywell International Inc. - Key news
Exhibits 116: Honeywell International Inc. - Key offerings
Exhibits 117: Honeywell International Inc. - Segment focus
Exhibits 118: Indegene Pvt. Ltd. - Overview
Exhibits 119: Indegene Pvt. Ltd. - Product / Service
Exhibits 120: Indegene Pvt. Ltd. - Key offerings
Exhibits 121: Oracle Corp. - Overview
Exhibits 122: Oracle Corp. - Business segments
Exhibits 123: Oracle Corp. - Key news
Exhibits 124: Oracle Corp. - Key offerings
Exhibits 125: Oracle Corp. - Segment focus
Exhibits 126: Sarjen Systems Pvt. Ltd. - Overview
Exhibits 127: Sarjen Systems Pvt. Ltd. - Product / Service
Exhibits 128: Sarjen Systems Pvt. Ltd. - Key offerings
Exhibits 129: United BioSource LLC - Overview
Exhibits 130: United BioSource LLC - Product / Service
Exhibits 131: United BioSource LLC - Key offerings
Exhibits 132: Inclusions checklist
Exhibits 133: Exclusions checklist
Exhibits 134: Currency conversion rates for US$
Exhibits 135: Research methodology
Exhibits 136: Information sources
Exhibits 137: Data validation
Exhibits 138: Validation techniques employed for market sizing
Exhibits 139: Data synthesis
Exhibits 140: 360 degree market analysis
Exhibits 141: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global pharmacovigilance and drug safety software market: AB Cube SARL, Accenture Plc, Advera Health Analytics Inc., ArisGlobal LLC, BaseCon AS, Clarivate PLC, Cognizant Technology Solutions Corp., Ennov SAS, EXTEDO GmbH, Honeywell International Inc., Indegene Pvt. Ltd., IQVIA Holdings Inc., Max Application Srl, Oracle Corp., Pegasystems Inc., Sarjen Systems Pvt. Ltd., United BioSource LLC, Veeva Systems Inc., and Wipro Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of ai in pharmacovigilance."

According to the report, one of the major drivers for this market is the rising incidence rates of adverse drug events.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AB Cube SARL
  • Accenture Plc
  • Advera Health Analytics Inc.
  • ArisGlobal LLC
  • BaseCon AS
  • Clarivate PLC
  • Cognizant Technology Solutions Corp.
  • Ennov SAS
  • EXTEDO GmbH
  • Honeywell International Inc.
  • Indegene Pvt. Ltd.
  • IQVIA Holdings Inc.
  • Max Application Srl
  • Oracle Corp.
  • Pegasystems Inc.
  • Sarjen Systems Pvt. Ltd.
  • United BioSource LLC
  • Veeva Systems Inc.
  • Wipro Ltd.